Early peek at data on Gilead coronavirus drug suggests patients are responding to treatment
Updated: Apr 20, 2020
Photo Credit: Louis Reed
A Chicago hospital treating severe COVID-19 patients with Gilead Sciences’ antiviral medicine Remdesivir in a closely watched clinical trial is seeing rapid recoveries in fever and respiratory symptoms, with nearly all patients discharged in less than a week.